Cover Image
Market Research Report

Global Smart Inhalers Market Forecast 2019-2028

Published by Inkwood Research Product code 945452
Published Content info 192 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Smart Inhalers Market Forecast 2019-2028
Published: June 30, 2020 Content info: 192 Pages
Description

KEY FINDINGS

The global smart inhalers market is projected to garner considerable revenue, growing at a CAGR of 31.66%, during the forecast period of 2019 to 2028. The drivers facilitating the market growth include a high incidence of chronic respiratory diseases like Chronic Obstructive Pulmonary Disease (COPD) and asthma, an increase in air pollution, and indoor air pollutants. Moreover, the growing geriatric population has also contributed to market growth.

MARKET INSIGHTS

Smart inhalers are used to deliver a variety of medications through inhalation. The drugs in the inhalers comprise glucocorticoids, anti-cholinergic, insulin, and beta-agonists for preventing and treating respiratory conditions like asthma and COPD. The inhalers are called smart inhalers due to the sensors clipped on them, monitoring the right dose, with each intake. The data registered by the sensor is shared with the patient and healthcare professionals to measure and track the inhaler use. The monitored information is then shared using Bluetooth technology to their mobile applications through a specific platform. The global smart inhalers market growth is propelled by the upsurge in the prevalence of COPD and asthma, which is caused by an increase in air pollution. Therefore, the high rates of air pollution are anticipated to cause a rise in respiratory disorders, which stimulates market growth. However, expensive treatments and limited availability of inhalers, hinder the global smart inhalers market growth.

REGIONAL INSIGHTS

The geographical segmentation of the global smart inhalers market comprises Asia Pacific, Europe, North America, and the rest of the world. Asia Pacific is estimated to project the highest CAGR, in terms of revenue, across the forecast period. Growing pollution rates in India, have led to a hike in the prevalence of respiratory diseases. This has significantly raised the demand for smart inhalers in the country, thereby propelling the market growth.

COMPETITIVE INSIGHTS

The global smart inhalers market is highly fragmented and comprises several large-scale and small-scale industries. Thus, intense competition is witnessed among participants. Companies stimulating the market growth include, ResMed Inc (Propeller Health), Novartis AG, GlaxoSmithKline Plc, Teva Pharmaceutical Industries Limited, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 32383

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. RISE IN AIR POLLUTION
    • 3.2.2. HIGH PREVALENCE OF CHRONIC RESPIRATORY DISEASES
    • 3.2.3. SURGING INDOOR AIR POLLUTANTS
    • 3.2.4. RISING GERIATRIC POPULATION
    • 3.2.5. GROWING PREVALENCE OF COPD AND ASTHMA
  • 3.3. KEY RESTRAINTS
    • 3.3.1. DATA SECURITY CONCERN HAMPERS THE MARKET
    • 3.3.2. HIGH COST OF ASTHMA AND COPD TREATMENT

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCE ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. EVOLUTION OF SMART INHALERS
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. KEY INVESTMENT INSIGHTS

5. MARKET BY PRODUCT

  • 5.1. SMART INHALERS
    • 5.1.1. DRY POWDER INHALER
    • 5.1.2. METERED DOSE INHALER
  • 5.2. SMART NEBULIZER
    • 5.2.1. TYPES OF NEBULIZER (QUALITATIVE)
      • 5.2.1.1. PNEUMATIC NEBULIZER
      • 5.2.1.2. ULTRASONIC NEBULIZER
      • 5.2.1.3. MESH NEBULIZER
    • 5.2.2. NEBULIZER BY PORTABILITY (QUALITATIVE)
      • 5.2.2.1. TABLETOP NEBULIZER
      • 5.2.2.2. PORTABLE NEBULIZER
    • 5.2.3. NEBULIZER BY SALES CHANNEL (QUALITATIVE)
      • 5.2.3.1. DIRECT PURCHASE
      • 5.2.3.2. ONLINE PURCHASE

6. MARKET BY INDICATION

  • 6.1. ASTHMA
  • 6.2. COPD

7. MARKET BY DISTRIBUTION CHANNEL

  • 7.1. HOSPITAL
  • 7.2. PHARMACY

8. GEOGRAPHICAL ANALYSIS

  • 8.1. NORTH AMERICA
    • 8.1.1. THE UNITED STATES
    • 8.1.2. CANADA
  • 8.2. EUROPE
    • 8.2.1. GERMANY
    • 8.2.2. FRANCE
    • 8.2.3. THE UNITED KINGDOM
    • 8.2.4. ITALY
    • 8.2.5. RUSSIA
    • 8.2.6. BELGIUM
    • 8.2.7. POLAND
    • 8.2.8. REST OF EUROPE
  • 8.3. ASIA PACIFIC
    • 8.3.1. JAPAN
    • 8.3.2. CHINA
    • 8.3.3. INDIA
    • 8.3.4. AUSTRALIA & NEW ZEALAND
    • 8.3.5. SOUTH KOREA
    • 8.3.6. THAILAND
    • 8.3.7. INDONESIA
    • 8.3.8. VIETNAM
    • 8.3.9. REST OF ASIA PACIFIC
  • 8.4. REST OF WORLD
    • 8.4.1. LATIN AMERICA
    • 8.4.2. MIDDLE EAST & AFRICA

9. COMPANY PROFILES

  • 9.1. 3M COMPANY
  • 9.2. ADHERIUM LIMITED
  • 9.3. AGILENT TECHNOLOGIES INC
  • 9.4. ASTRAZENECA PLC
  • 9.5. BOEHRINGER INGELHEIM GMBH
  • 9.6. COHERO HEALTH INC
  • 9.7. GLAXOSMITHKLINE PLC
  • 9.8. KONINKLIJKE PHILIPS N.V
  • 9.9. NOVARTIS AG
  • 9.10. OPKO HEALTH INC
  • 9.11. RESMED INC (PROPELLER HEALTH)
  • 9.12. TEVA PHARMACEUTICAL INDUSTRIES LIMITED
  • 9.13. VECTURA GROUP PLC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - SMART INHALERS
  • TABLE 2: GLOBAL SMART INHALERS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 3: GLOBAL SMART INHALERS MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
  • TABLE 4: GLOBAL SMART INHALERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 5: GLOBAL SMART INHALERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
  • TABLE 6: GLOBAL SMART INHALERS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 7: GLOBAL SMART INHALERS MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
  • TABLE 8: GLOBAL SMART NEBULIZER MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 9: GLOBAL SMART NEBULIZER MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
  • TABLE 10: GLOBAL SMART INHALERS MARKET, BY INDICATION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 11: GLOBAL SMART INHALERS MARKET, BY INDICATION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
  • TABLE 12: GLOBAL ASTHMA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 13: GLOBAL ASTHMA MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
  • TABLE 14: GLOBAL COPD MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 15: GLOBAL COPD MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
  • TABLE 16: GLOBAL SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 17: GLOBAL SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
  • TABLE 18: GLOBAL HOSPITAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 19: GLOBAL HOSPITAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
  • TABLE 20: GLOBAL PHARMACY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 21: GLOBAL PHARMACY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
  • TABLE 22: GLOBAL SMART INHALERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 23: GLOBAL SMART INHALERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
  • TABLE 24: NORTH AMERICA SMART INHALERS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 25: NORTH AMERICA SMART INHALERS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
  • TABLE 26: EUROPE SMART INHALERS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 27: EUROPE SMART INHALERS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
  • TABLE 28: ASIA PACIFIC SMART INHALERS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 29: ASIA PACIFIC SMART INHALERS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
  • TABLE 30: REST OF WORLD SMART INHALERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 31: REST OF WORLD SMART INHALERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)

LIST OF FIGURES

  • FIGURE 1: GLOBAL POPULATION, BY AGE GROUP 2015 & 2020 (IN MILLION)
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: KEY INVESTMENT INSIGHTS
  • FIGURE 6: GLOBAL SMART INHALERS MARKET, BY PRODUCT, IN 2019
  • FIGURE 7: GLOBAL SMART INHALERS MARKET, BY SMART INHALERS, 2019-2028 (IN $ THOUSAND)
  • FIGURE 8: GLOBAL SMART INHALERS MARKET, BY DRY POWDER INHALER, 2019-2028 (IN $ THOUSAND)
  • FIGURE 9: GLOBAL SMART INHALERS MARKET, BY METERED DOSE INHALER, 2019-2028 (IN $ THOUSAND)
  • FIGURE 10: GLOBAL SMART INHALERS MARKET, BY SMART NEBULIZER, 2019-2028 (IN $ THOUSAND)
  • FIGURE 11: GLOBAL SMART INHALERS MARKET, BY INDICATION, IN 2019
  • FIGURE 12: GLOBAL SMART INHALERS MARKET, BY ASTHMA, 2019-2028 (IN $ THOUSAND)
  • FIGURE 13: GLOBAL SMART INHALERS MARKET, BY COPD, 2019-2028 (IN $ THOUSAND)
  • FIGURE 14: GLOBAL SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, IN 2019
  • FIGURE 15: GLOBAL SMART INHALERS MARKET, BY HOSPITAL, 2019-2028 (IN $ THOUSAND)
  • FIGURE 16: GLOBAL SMART INHALERS MARKET, BY PHARMACY, 2019-2028 (IN $ THOUSAND)
  • FIGURE 17: NORTH AMERICA SMART INHALERS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 18: THE UNITED STATES SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 19: CANADA SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 20: EUROPE SMART INHALERS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 21: GERMANY SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 22: FRANCE SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 23: THE UNITED KINGDOM SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 24: ITALY SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 25: RUSSIA SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 26: BELGIUM SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 27: POLAND SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 28: REST OF EUROPE SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 29: ASIA PACIFIC SMART INHALERS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 30: JAPAN SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 31: CHINA SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 32: INDIA SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 33: AUSTRALIA & NEW ZEALAND SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 34: SOUTH KOREA SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 35: THAILAND SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 36: INDONESIA SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 37: VIETNAM SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 38: REST OF ASIA PACIFIC SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 39: REST OF WORLD SMART INHALERS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 40: LATIN AMERICA SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 41: MIDDLE EAST & AFRICA SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
Back to Top